Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide

被引：6
|
作者：
Nandipati, Sirisha
Demopoulos, Alexis [1 ,2 ,3 ]
机构：
[1] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Neurosurg, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
来源：
JOURNAL OF NEURO-ONCOLOGY | 2011年 / 105卷 / 03期
关键词：
GLIOBLASTOMA;
D O I：
10.1007/s11060-011-0611-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 665
页数：3
相关论文
共 50 条
  • [41] Effect of RPA class in patients with anaplastic astrocytoma and glioblastoma treated with IMRT, with and without concurrent temozolomide
    Flickinger, J. C.
    Rakfal, S.
    Heron, D. E.
    Beriwal, S.
    Smith, R. P.
    Jones, H.
    Huq, M. S.
    Bahri, S.
    Lieberman, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S237 - S237
  • [42] MGMT METHYLATION IS A POSITIVE PROGNOSTIC MARKER IN PATIENTS WITH ANAPLASTIC ASTROCYTOMA TREATED WITH CONCURRENT TEMOZOLOMIDE AND RADIATION
    Blumenthal, Deborah
    Bokstein, Felix
    Zelikovitsh, Bracha
    Mordechai, Anat
    Lossos, Alexander
    Taliansky, Alisa
    Zach, Lior
    Tzuk-Shina, Tzahallah
    Lavon, Iris
    NEURO-ONCOLOGY, 2014, 16
  • [43] Health related quality of life in 10 patients with anaplastic gliomas treated with temozolomide and radiation therapy
    Scapati, A
    Barbara, R
    Giovannini, P
    Pecchia, R
    Ascarelli, AA
    TUMORI JOURNAL, 2001, 87 (04): : S154 - S155
  • [44] PRIMARY LEPTOMENINGEAL ANAPLASTIC OLIGODENDROGLIOMA WITH A 1P36-19Q13 DELETION: REPORT OF A UNIQUE CASE SUCCESSFULLY TREATED WITH TEMOZOLOMIDE
    Michotte, A.
    Chaskis, C.
    Neyns, B.
    Tyberghien, A.
    Declerck, M.
    Origer, I.
    Sadones, J.
    Veld, P. In't
    NEURO-ONCOLOGY, 2008, 10 (06) : 1087 - 1088
  • [45] Leukopenia as a Possible Biomarker for Overall Survival in Glioblastoma Patients Treated with Temozolomide
    Ho, Ka-wai G.
    Wong, Eric T.
    Uhlmann, Erik J.
    NEUROLOGY, 2018, 90
  • [46] Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma
    Duerinck, Johnny
    Du Four, Stephanie
    Sander, Wilhelm
    Van Binst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Hau, Peter
    Neyns, Bart
    ANTICANCER RESEARCH, 2015, 35 (10) : 5551 - 5557
  • [47] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Koekkoek, Johan A. F.
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (02) : 347 - 354
  • [48] DIFFUSE LARGE B-CELL LYMPHOMA IN GLIOMA PATIENTS TREATED WITH TEMOZOLOMIDE CHEMOTHERAPY
    Cordera, S.
    Bottacchi, E.
    Alvaro, M.
    Joossens, E.
    Neyns, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1119 - 1120
  • [49] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Johan A. F. Koekkoek
    Linda Dirven
    Jan J. Heimans
    Tjeerd J. Postma
    Maaike J. Vos
    Jaap C. Reijneveld
    Martin J. B. Taphoorn
    Journal of Neuro-Oncology, 2016, 126 : 347 - 354
  • [50] SURVIVAL OF PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA TREATED WITH TEMOZOLOMIDE, IRINOTECAN AND BEVACIZUMAB AT SEATTLE CHILDREN'S HOSPITAL
    Uparkar, Urmila
    Geyer, Russell
    Ermoian, Ralph
    Ellenbogen, Richard
    Leary, Sarah
    NEURO-ONCOLOGY, 2012, 14 : 62 - 62
12345